u/lurker_for_years

receptor agonism is not the same as receptor activation in every tissue

Adding the caveat the paper itself makes in its limitations section, which is stronger than anything in this thread.

If your calculation produces a fraction of a unit, the concentration is wrong for your dose. Change the water volume until the numbers land on whole units.

A test transaction costs one extra network fee and verifies the address, the network and the recipient’s crediting process before the main amount moves.

Nearly sent on the wrong network. The token symbol was identical and the address format was the only clue.

The failure modes I have actually seen posted here, in order of frequency.

One: reconstituting at a different volume than intended and not writing it down, so the next draw is based on a remembered concentration. Two: treating units as a dose rather than a volume, which breaks the moment the concentration changes. Three: assuming a syringe is U-100 when it is not.

All three are solved by the same two habits — do the arithmetic before the water goes in, and write the result on the glass. Neither costs anything and between them they cover almost every question this board gets.

Memo requirements are chain-specific. The chain you are describing does not use one.

Aim the stream down the wall of the vial rather than into the cake. Reconstitution is a solubility problem, not a mixing problem, and mechanical shear does nothing helpful.

Why "more water" keeps confusing people, including me for a month.

The vial contains a fixed amount of peptide. Water changes nothing about that amount. What it changes is concentration, and concentration is the divisor between the dose you want and the volume you draw.

So doubling the water halves the concentration and doubles the units for the same dose. Nothing is diluted in any sense that matters; you are simply reading a bigger number off the same barrel. Pick the water volume that puts your usual dose on a whole number of units and life gets easier.

Small fix — three receptors, not two. GLP-1, GIP and glucagon, and the third one is the reason this compound gets its own board.

phase 2 data only, and people quote it like it is a label

the escalation is where most of the reported trouble sits

That study was in a rodent model. Worth stating, since the thread has been reading it as human data.

Some chains require a memo or destination tag to route funds to the right account. Omitting it on those chains is one of the more common ways payments go astray.

Phase 2 estimates effect and finds a dose range. Phase 3 estimates it precisely in a bigger population and catches what phase 2 was too small to see. Treating them as the same tier of evidence is the recurring error here.

Yes — the same token symbol on two chains catches people constantly and it is unrecoverable.

Escrow is not standard in this space. Wanting it is reasonable; expecting it as default is not.

Increases in heart rate have been reported across this receptor class. The magnitude and clinical significance are exactly what phase 3 is powered to establish.

Small fix — a U-100 syringe is 100 units per mL. If yours is marked differently it is not U-100 and the whole calculation changes.

Reconstituted at 3mL when I meant to use a different volume. Caught it because the units looked wrong on the barrel. Now I write 10mg/mL on the glass before I put the cap back.

the phase 2 numbers were striking and they were also 48 weeks in a small population

Is that from a human study or a preclinical model?

Adding the caveat the paper itself makes in its limitations section, which is stronger than anything in this thread.

label the vial with the date as well as the concentration

Adding the standing caveat: none of this is approved anywhere and research material is not for human use.

Disagree with this specific inference. A 48-week readout does not tell you the shape of the curve after it.

What is and is not the supplier’s fault, since this board generates unfair complaints.

Not theirs: the network fee, chain congestion, confirmation time, the rate moving between quote and send, and a payment sent on the wrong chain. Theirs: which networks they accept, how quickly they credit a confirmed payment, and whether the address they gave you was correct and communicated clearly.

Keeping those columns separate makes the reports here far more useful. A thread titled "supplier took my payment" that turns out to describe forty minutes of unconfirmed transaction helps nobody and follows people around for years.

Glucose-dependent insulin secretion is why hypoglycaemia risk is low as monotherapy: the effect scales with glycaemia rather than acting unconditionally.

dose response is not linear and nobody should assume it is

Are you comparing against phase 3 numbers for something else? They are not comparable.

What do you think the glucagon component is adding, specifically?

Glucose-dependent insulin secretion is why hypoglycaemia risk is low as monotherapy: the effect scales with glycaemia rather than acting unconditionally.

30mg into 3mL is 10mg/mL, and 1.5mg of that is 15 units

swirl, never shake

Is that a U-100 syringe? The barrel markings change the answer completely.

Where the evidence actually stands, since every thread here assumes a different answer.

Phase 2 reported a large mean body weight change at 48 weeks across a few hundred participants with a slow, protocol-driven escalation. The effect size was striking. The confidence intervals were wide, the population was small, and the duration was under a year.

Phase 3 is running. Until it reports, everything else — including the ranking arguments this board loves — is extrapolation from a small study. That is not a criticism of the compound; it is a description of the evidence.

This. A test transaction on a large order costs a fraction of the fee and removes the whole class of risk.

nothing here is available as a prescription product, so read every thread with that in mind

That only works if the fill weight is exactly the label weight, and it usually is not exactly anything.

Speculation is welcome here if it is labelled.

gastric_emptying_g is right that mechanism gives direction and not magnitude. Worth pinning.